(Q46313699)

English

A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

liver transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Peter W Angus

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

Scott J Patterson

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

Simone I Strasser

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

Geoffrey W McCaughan

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

Edward Gane

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

language of work or name

0 references

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

48

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

1460-1466

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Adefovir dipivoxil for wait-listed and post–liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

21 January 2018

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose [...]

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.22524

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.22524

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

release_pvegsc2fznbxbopz5wf4g2bkju

1 reference

https://api.fatcat.wiki/v0/release/pvegsc2fznbxbopz5wf4g2bkju

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18925641

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46313699&oldid=2104510465"